Skip to main content
GUANGXI LIUYAO GROUP CO., LTD logo

GUANGXI LIUYAO GROUP CO., LTD — Investor Relations & Filings

Ticker · 603368 ISIN · CNE100001VR3 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2026-05-20 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 603368

About GUANGXI LIUYAO GROUP CO., LTD

http://web.lzyy.cn/

Guangxi Liuyao Group Co., Ltd. is a comprehensive healthcare enterprise specializing in pharmaceutical distribution, retail, and manufacturing. The company operates an extensive wholesale network supplying hospitals and medical institutions with a wide range of products, including Western pharmaceuticals, traditional Chinese medicines (TCM), and medical devices. Its retail division manages a significant chain of pharmacies, providing direct consumer access to healthcare products. Beyond distribution, the group is involved in the production of TCM decoction pieces and finished pharmaceutical products. Leveraging advanced logistics and supply chain management systems, the company provides integrated services to the healthcare sector, focusing on optimizing the delivery and availability of medical supplies. Its business model integrates upstream manufacturing with downstream retail and clinical supply, establishing a robust presence across the pharmaceutical value chain.

Recent filings

Filing Released Lang Actions
广东华商律师事务所关于广西柳药集团股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is a legal opinion letter regarding the company’s 2025 Annual General Meeting, detailing the convening procedures, participant qualifications, voting procedures and the precise vote counts for each resolution. This aligns with "Declaration of Voting Results & Voting Rights Announcements" (DVA), as it formally reports and verifies the AGM voting outcomes.
2026-05-20 Chinese
广西柳药集团股份有限公司关于召开2025年年度股东会的提示性公告
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal announcement by Guangxi Liuyao Group Co., Ltd. regarding the convening of its 2025 Annual Shareholders’ Meeting, detailing the meeting date, agenda items, voting procedures, and including a proxy authorization form. It is not the annual report itself or financial statements, nor is it a results announcement. Instead, it is information and materials (including the proxy form) sent to shareholders to inform them of the meeting and solicit their votes. This corresponds to the “Proxy Solicitation & Information Statement” category (PSI).
2026-05-15 Chinese
广西柳药集团股份有限公司关于为下属控股子公司提供担保的进展公告
Regulatory Filings Classification · 86% confidence The document is a formal announcement by Guangxi Liuzhou Pharmaceutical Group Co., Ltd. to disclose the progress of guarantees provided to its wholly‐owned/controlled subsidiary. It is not an annual or interim report, earnings release, or management discussion; nor does it announce publication of another report. It is a regulatory announcement of contingent liability/guarantee arrangements under stock exchange rules, which does not fit any specialized category. Therefore, it is classified as a general regulatory filing (RNS).
2026-05-12 Chinese
广西柳药集团股份有限公司2025年年度股东会会议文件
AGM Information Classification · 94% confidence The document is a comprehensive set of meeting materials for the 2025 Annual General Meeting (AGM) of Guangxi Liuyao Group Co., Ltd., including the AGM agenda, voting instructions, detailed proposals (board report, financial statements, budget plan, profit distribution, capital changes, governance proposals, etc.), and meeting logistics. It is clearly the materials distributed for the AGM rather than the standalone annual report or voting results. Therefore, it falls under AGM Information (AGM-R).
2026-05-11 Chinese
独立董事候选人声明与承诺（马念谊）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate, detailing qualifications, independence criteria, and compliance with regulatory requirements. It is not a financial report, earnings release, or management discussion. It does not announce voting results or changes in board members but is a formal statement related to board candidate qualifications. This type of document fits best under Board/Management Information (MANG), as it pertains to board member nomination and qualifications.
2026-03-13 Chinese
广西柳药集团股份有限公司第五届董事会第三十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Guangxi Liuyue Group Co., Ltd. It details the convening of the 32nd meeting of the 5th board, the nomination of candidates for the 6th board, and the proposal to convene an extraordinary general meeting. The content focuses on board decisions and nominations, with no financial data or report attached. It is not a full annual or interim report, nor an earnings release. It is not a proxy solicitation or voting results announcement, but a board meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes or nominations in the board of directors or senior management.
2026-03-13 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.